It takes a village to beat visual system diseases in children

Community support is the most important factor in ascertaining effective treatments for paediatric eye diseases.

Risks and management of diabetic retinopathy in paediatric patients

Diabetes mellitus, which is a common chronic disease in children, can lead to significant eye morbidities with long-lasting effects, including diabetic retinopathy. Treatment should be tailored to the individual patient.

Roche’s DME candidate hits mark in 2 global Phase 3 studies

Faricimab is the focus of the YOSEMITE and RHINE studies, which investigators say show that the investigational bispecific antibody has the potential to offer lasting vision improvements for patients with diabetic macular oedema.

AAO: Fingolimod for MS offers disease control with no development of uveitis

November 15, 2020

Bradley Smith, MD, presents at AAO 2020 on how fingolimod 0.5 mg, a first-line treatment for multiple sclerosis, may reduce both the number of relapses and disease progression in patients with relapsing-remitting MS as well as the incidence of uveitis.

The importance of recognising Charles Bonnet syndrome in children

November 15, 2020

A case series of 13 young patients with Charles Bonnet syndrome, which is characterised by visual hallucinations in individuals who are experiencing sight loss, showed that the patients all had inherited retinal diseases or congenital eye disorders but there was no link with visual dysfunction.

AAO: Alimera highlights NEW DAY Study for sustained-release intravitreal implant

November 15, 2020

Rick Eiswirth, president and CEO of Alimera Sciences, provides an update on the company’s clinical trial that aims to evaluate its fluocinolone acetonide intravitreal implant 0.19 mg (Iluvien) as a baseline therapy for diabetic macular edema.